The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice

Differential Regulation of Chemokines by IL-17 in Colonic Epithelial Cells

(2014) J. W. Lee et al.   JOURNAL OF IMMUNOLOGY

Lipid Droplet Accumulation Is Associated with an Increase in Hyperglycemia-Induced Renal Damage

(2013) Eva Kiss et al.   AMERICAN JOURNAL OF PATHOLOGY

Targeting liver X receptors in inflammation

(2013) Knut R Steffensen et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile

(2012) X. Hu et al.   JOURNAL OF INTERNAL MEDICINE

Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking liver X receptor  

(2012) C. Gabbi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Liver X receptor biology and pharmacology: new pathways, challenges and opportunities

(2012) Tomas Jakobsson et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Suppression of Chronic Damage in Renal Allografts by Liver X Receptor (LXR) Activation

(2011) Eva Kiss et al.   AMERICAN JOURNAL OF PATHOLOGY

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

(2011) Natalie A. Molodecky et al.   GASTROENTEROLOGY

Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation

(2011) Guoliang Cui et al.   JOURNAL OF CLINICAL INVESTIGATION

Selective liver X receptor modulators (SLiMs): What use in human health?

(2011) Emilie Viennois et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Coronin 2A mediates actin-dependent de-repression of inflammatory response genes

(2011) Wendy Huang et al.   NATURE

Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease

(2011) Vibeke Andersen   WORLD JOURNAL OF GASTROENTEROLOGY

Tissue-Specific Liver X Receptor Activation Promotes Macrophage Reverse Cholesterol Transport In Vivo

(2010) Tomoyuki Yasuda et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Chemokines in Inflammatory Bowel Diseases

(2010) Raja Atreya et al.   DIGESTIVE DISEASES

GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXR  in the hepatic acute phase response

(2010) N. Venteclef et al.   GENES & DEVELOPMENT

Activation of Liver X Receptor Sensitizes Human Dendritic Cells to Inflammatory Stimuli

(2010) D. Torocsik et al.   JOURNAL OF IMMUNOLOGY

Inside the microbial and immune labyrinth: Totally gutted

(2010) Thomas T MacDonald   NATURE MEDICINE

Chemokines and chemokine receptors: new insights into cancer-related inflammation

(2010) Gwendal Lazennec et al.   TRENDS IN MOLECULAR MEDICINE

Differential regulation of interleukin 17 and interferon   production in inflammatory bowel disease

(2009) L. Rovedatti et al.   GUT

Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity

(2009) Jihong Xu et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Differential SUMOylation of LXRα and LXRβ Mediates Transrepression of STAT1 Inflammatory Signaling in IFN-γ-Stimulated Brain Astrocytes

(2009) Jee Hoon Lee et al.   MOLECULAR CELL

GPS2 Is Required for Cholesterol Efflux by Triggering Histone Demethylation, LXR Recruitment, and Coregulator Assembly at the ABCG1 Locus

(2009) Tomas Jakobsson et al.   MOLECULAR CELL

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

LIVER X RECEPTOR AGONIST GW3965 DOSE-DEPENDENTLY REGULATES LPS-MEDIATED LIVER INJURY AND MODULATES POSTTRANSCRIPTIONAL TNF-α PRODUCTION AND P38 MITOGEN-ACTIVATED PROTEIN KINASE ACTIVATION IN LIVER MACROPHAGES

(2009) Yun Yong Wang et al.   SHOCK

LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response

(2008) Steven J. Bensinger et al.   CELL